MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
SSKN - STRATA Skin Sciences Inc
$1.83
-0.02(-1.08%)9:00:00 PM 2/26/2021
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. The company distributes its products internationally through distributors, and domestically directly to physicians. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.
Stock Statistics
MarketCap62.5M
PE Ratio-14.1
PEG Ratio-0.6
P/B2.5
P/S (ttm)2.6
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %1%
Held by Institutions %73%
1 Day Vol Adjusted Return0.0
1 Month Vol Adjusted Return2.6
3 Month Vol Adjusted Return3.4
6 Month Vol Adjusted Return3.4
20 Days SMA Price ZScore-0.8
50 Days SMA Price ZScore0.3
12 -26 Days PPO3.1
1 Month Average Short Volume Ratio44.4
1 Day Volume Change ZScore-0.7
1 Month Daily Vol5.9
Related Topics
leak data

Related Topics

Peers

Related Peers

Stock news

    01/12/2021SSKN
    STRATA Skin Sciences Announces Preliminary Fourth Quarter 2020 Financial Results and Operational Metrics

    Preliminary, unaudited fourth quarter revenues in the range of $6.6 million to $6.8 million  Preliminary, unaudited fourth quarter recurring revenues in the range of $5.0 million to $5.2 million Worldwide installed base increased by 23 placements in the fourth quarterHORSHAM, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products ...

    01/12/2021SSKN
    STRATA Skin Sciences Announces the Introduction of “Home by XTRAC™”

    HORSHAM, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the introduction of a new business, branded “Home by XTRAC™”.  * Provides an at-home, insurance-reimbursed treatment option for patients with certain skin diseases that do not qualify for in-office treatm...

    01/6/2021SSKN
    STRATA Skin Sciences to Participate in the H.C. Wainwright BioConnect Virtual Conference

    HORSHAM, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the upcoming H.C. Wainwright BioConnect Virtual Conference. Dates: Monday, January 11 to Thursday, January 14, 2021 Format: Presentation availabl...

    12/28/2020SSKN
    STRATA Skin Sciences, Inc. Announces Successful Renewal of Note Payable

    HORSHAM, Pa., Dec. 28, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it has renewed its existing debt with a lower interest one-year cash secured loan facility with Israel Discount Bank of New York, a multinational commercial bank. The new loa...

    11/27/2020SSKN
    Where Do Hedge Funds Stand On Strata Skin Sciences, Inc. (SSKN)?

    In this article we will check out the progression of hedge fund sentiment towards Strata Skin Sciences, Inc. (NASDAQ:SSKN) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 […]

    11/10/2020SSKN
    What We Learned About STRATA Skin Sciences' (NASDAQ:SSKN) CEO Pay

    Dolev Rafaeli has been the CEO of STRATA Skin Sciences, Inc. (NASDAQ:SSKN) since 2018, and this article will examine...

    11/10/2020SSKN
    Strata Skin Sciences: Q3 Earnings Insights

    Shares of Strata Skin Sciences (NASDAQ:SSKN) remained unaffected after the company reported Q3 results.Quarterly Results Earnings per share fell 33.33% year over year to ($0.04), which were in line with the estimate of ($0.04).Revenue of $5,613,000 decreased by 24.96% year over year, which beat the estimate of $4,900,000.Outlook Strata Skin Sciences hasn't issued any earnings guidance for the time being.Strata Skin Sciences hasn't issued any revenue guidance for the time being.How To Listen To T...

    11/10/2020SSKN
    STRATA Skin Sciences Reports Third Quarter 2020 Financial Results

    HORSHAM, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended September 30, 2020. Recent Highlights * Total revenue for the third quarter of 2020 was $5.6 million, a decrease of 25.0% over the third quarter of 2019 ...